Long QT Syndrome genetic studies: Difference between revisions
Farima Kahe (talk | contribs) No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Long QT Syndrome}} | {{Long QT Syndrome}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Either compressive testing for all variants of LQTs or for the LQTs 1-3 variants is recommended in any patient in whom there is a strong clinical suspicion based on the family history, symptoms, resting [[EKG]], provoked findings on an exercise treadmill test or during [[catecholamine]] infusion. Genetic studies remain to be the gold standard in the diagnosis of long QT syndrome. | Either compressive testing for all variants of LQTs or for the LQTs 1-3 variants is recommended in any patient in whom there is a strong clinical suspicion based on the family history, symptoms, resting [[EKG]], provoked findings on an exercise treadmill test or during [[catecholamine]] infusion. Genetic studies remain to be the gold standard in the diagnosis of long QT syndrome. | ||
==Genetic studies== | |||
===LQT 1 Genetics=== | ===LQT 1 Genetics=== | ||
The [[LQT1]] [[gene]] is {{gene|KCNQ1}} which has been isolated to [[chromosome]] 11p15.5. KCNQ1 codes for the voltage-gated potassium channel [[KvLQT1]] that is highly expressed in the heart. It is believed that the product of the KCNQ1 gene produces an alpha subunit that interacts with other proteins (particularly the minK beta subunit) to create the I<sub>Ks</sub> ion channel, which is responsible for the delayed potassium rectifier current of the [[cardiac action potential]]. Mutations to the KCNQ1 gene can be inherited in an [[autosomal dominant]] or an[[autosomal recessive]] pattern in the same family. In the autosomal recessive mutation of this gene,[[homozygous]] mutations in KVLQT1 leads to severe prolongation of the QT interval (due to near-complete loss of the I<sub>Ks</sub> ion channel), and is associated with increased risk of ventricular arrhythmias and congenital deafness. | The [[LQT1]] [[gene]] is {{gene|KCNQ1}} which has been isolated to [[chromosome]] 11p15.5. KCNQ1 codes for the voltage-gated potassium channel [[KvLQT1]] that is highly expressed in the heart. It is believed that the product of the KCNQ1 gene produces an alpha subunit that interacts with other proteins (particularly the minK beta subunit) to create the I<sub>Ks</sub> ion channel, which is responsible for the delayed potassium rectifier current of the [[cardiac action potential]]. Mutations to the KCNQ1 gene can be inherited in an [[autosomal dominant]] or an[[autosomal recessive]] pattern in the same family. In the autosomal recessive mutation of this gene,[[homozygous]] mutations in KVLQT1 leads to severe prolongation of the QT interval (due to near-complete loss of the I<sub>Ks</sub> ion channel), and is associated with increased risk of ventricular arrhythmias and congenital deafness. |
Revision as of 19:25, 6 April 2020
Long QT Syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Long QT Syndrome genetic studies On the Web |
American Roentgen Ray Society Images of Long QT Syndrome genetic studies |
Risk calculators and risk factors for Long QT Syndrome genetic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Either compressive testing for all variants of LQTs or for the LQTs 1-3 variants is recommended in any patient in whom there is a strong clinical suspicion based on the family history, symptoms, resting EKG, provoked findings on an exercise treadmill test or during catecholamine infusion. Genetic studies remain to be the gold standard in the diagnosis of long QT syndrome.
Genetic studies
LQT 1 Genetics
The LQT1 gene is KCNQ1 which has been isolated to chromosome 11p15.5. KCNQ1 codes for the voltage-gated potassium channel KvLQT1 that is highly expressed in the heart. It is believed that the product of the KCNQ1 gene produces an alpha subunit that interacts with other proteins (particularly the minK beta subunit) to create the IKs ion channel, which is responsible for the delayed potassium rectifier current of the cardiac action potential. Mutations to the KCNQ1 gene can be inherited in an autosomal dominant or anautosomal recessive pattern in the same family. In the autosomal recessive mutation of this gene,homozygous mutations in KVLQT1 leads to severe prolongation of the QT interval (due to near-complete loss of the IKs ion channel), and is associated with increased risk of ventricular arrhythmias and congenital deafness.
LQT 2 Genetics
The LQT2 form of long QT syndrome most likely involves mutations of the human ether-a-go-go related gene (HERG) on chromosome 7. The HERG gene (also known as KCNH2) is part of the rapid component of the potassium rectifying current (IKr). (The IKr current is mainly responsible for the termination of the cardiac action potential, and therefore the length of the QT interval.) The normally functioning HERG gene allows protection against early after depolarizations (EADs).
LQT 3 Genetics
This variant involves a mutation of the gene that encodes the alpha subunit of the Na+ ion channel. This gene is located on chromosome 3p21-24, and is known as SCN5A (also hH1 and NaV1.5). The mutations involved in LQT3 slow the inactivation of the Na+ channel, resulting in prolongation of the Na+ influx during depolarization. A large number of mutations have been characterized as leading to or predisposing LQT3.